Search Results - "PRUNEAU, D"

Refine Results
  1. 1

    Stable expression of human kinin B 1 receptor in 293 cells: pharmacological and functional characterization by Bastian, S., Loillier, B., Paquet, J. L., Pruneau, D.

    Published in British journal of pharmacology (05-02-2009)
    “…We compared the binding properties of [ 3 H]‐desArg 10 ‐[Leu 9 ]‐kallidin, a radiolabelled kinin B 1 receptor antagonist, to membranes from IMR‐90 human…”
    Get full text
    Journal Article
  2. 2

    Effect of warming and flow rate conditions of blood warmers on red blood cell integrity by Poder, T. G., Pruneau, D., Dorval, J., Thibault, L., Fisette, J.-F., Bédard, S. K., Jacques, A., Beauregard, P.

    Published in Vox sanguinis (01-11-2016)
    “…Background and Objectives Fluid warmers are routinely used to reduce the risk of hypothermia and cardiac complications associated with the infusion of cold…”
    Get full text
    Journal Article
  3. 3

    Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia by ZAUSINGER, S, LUMENTA, D. B, PRUNEAU, D, SCHMID-ELSAESSER, R, PLESNILA, N, BAETHMANN, A

    Published in Brain research (20-09-2002)
    “…Bradykinin, an endogenous nonapeptide produced by activation of the kallikrein-kinin system, promotes neuronal tissue damage as well as disturbances in…”
    Get full text
    Journal Article
  4. 4

    Activation of liver X receptors promotes lipid accumulation but does not alter insulin action in human skeletal muscle cells by Cozzone, D, Debard, C, Dif, N, Ricard, N, Disse, E, Vouillarmet, J, Rabasa-Lhoret, R, Laville, M, Pruneau, D, Rieusset, J, Lefai, E, Vidal, H

    Published in Diabetologia (01-05-2006)
    “…The aim of this study was to investigate the effects of liver X receptor (LXR) activation on lipid metabolism and insulin action in human skeletal muscle cells…”
    Get full text
    Journal Article
  5. 5

    Detrimental role of bradykinin B2 receptor in a murine model of diffuse brain injury by Hellal, F, Pruneau, D, Palmier, B, Faye, P, Croci, N, Plotkine, M, Marchand-Verrecchia, C

    Published in Journal of neurotrauma (01-09-2003)
    “…Inhibition of the bradykinin B2 receptor type (B2R) has been shown to improve neurological outcome in models of focal traumatic brain injury. However, the…”
    Get more information
    Journal Article
  6. 6

    Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia by LUMENTA, D. B, PLESNILA, N, KLÄSNER, B, BAETHMANN, A, PRUNEAU, D, SCHMID-ELSAESSER, R, ZAUSINGER, S

    Published in Brain research (19-01-2006)
    “…Bradykinin, an endogenous nonapeptide produced by activation of the kallikrein-kinin system, promotes neuronal tissue damage as well as disturbances in…”
    Get full text
    Journal Article
  7. 7

    Neuroprotective effects of a postischemic treatment with a bradykinin B 2 receptor antagonist in a rat model of temporary focal cerebral ischemia by Lumenta, D.B., Plesnila, N., Kläsner, B., Baethmann, A., Pruneau, D., Schmid-Elsaesser, R., Zausinger, S.

    Published in Brain research (19-01-2006)
    “…Bradykinin, an endogenous nonapeptide produced by activation of the kallikrein–kinin system, promotes neuronal tissue damage as well as disturbances in…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization by Bastian, S., Loillier, B., Paquet, J. L., Pruneau, D.

    Published in British journal of pharmacology (01-09-1997)
    “…1 We compared the binding properties of [3H]‐desArg10‐[Leu9]‐kallidin, a radiolabelled kinin B1 receptor antagonist, to membranes from IMR‐90 human embryonic…”
    Get full text
    Journal Article
  10. 10

    Therapeutical efficacy of a novel non-peptide bradykinin B2 receptor antagonist on brain edema formation and ischemic tissue damage in focal cerebral ischemia by Zausinger, S, Lumenta, D B, Pruneau, D, Schmid-Elsaesser, R, Plesnila, N, Baethmann, A

    Published in Acta neurochirurgica. Supplement (2003)
    “…Bradykinin has been identified as a mediator of secondary brain damage in acute insults. We currently studied neuroprotective properties of a bradykinin B2…”
    Get more information
    Journal Article
  11. 11

    Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide‐treated rats by Belichard, P, Luccarini, J M, Defrêne, E, Faye, P, Franck, R M, Duclos, H, Paquet, J L, Pruneau, D

    Published in British journal of pharmacology (01-09-1999)
    “…In the present study, we developed an experimental model of cystitis induced by cyclophosphamide (CYP). In order to characterize des‐Arg9‐BK‐induced…”
    Get full text
    Journal Article
  12. 12

    A Rational Approach to the Design and Synthesis of a New Bradykinin B1 Receptor Antagonist by Bedos, Philippe, Amblard, Muriel, Subra, Gilles, Dodey, Pierre, Luccarini, Jean-Michel, Paquet, Jean-Luc, Pruneau, Didier, Aumelas, André, Martinez, Jean

    Published in Journal of medicinal chemistry (15-06-2000)
    “…We have previously synthesized a potent and selective B1 bradykinin receptor antagonist, JMV1645 (H-Lys-Arg-Pro-Hyp-Gly-Igl-Ser-D-BT-OH), containing a…”
    Get full text
    Journal Article
  13. 13

    Induction of kinin B1 receptor‐dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery by Pruneau, D., Luccarini, J.M., Robert, C., Bélichard, P.

    Published in British journal of pharmacology (01-04-1994)
    “…1 Balloon catheter injury to the rabbit carotid artery damaged the endothelium and induced neointima formation over 7 days. The area of intima, expressed as a…”
    Get full text
    Journal Article
  14. 14

    Pharmacological and functional characterization of the guinea‐pig B2 bradykinin receptor stably expressed in CHO‐K1 cell line by Robert, C, Pruneau, D, Paquet, J ‐L

    Published in British journal of pharmacology (01-01-2002)
    “…In the present study, pharmacological properties of a bradykinin B2 receptor amplified either from guinea‐pig ileum or lung and homologous to the previously…”
    Get full text
    Journal Article
  15. 15

    Pharmacological characterization of the bradykinin B2 receptor: inter‐species variability and dissociation between binding and functional responses by Paquet, J ‐L, Luccarini, J ‐M, Fouchet, C, Defrêne, E, Loillier, B, Robert, C, Bélichard, P, Cremers, B, Pruneau, D

    Published in British journal of pharmacology (01-03-1999)
    “…The present study addresses the differences in binding profiles and functional properties of the human and rat bradykinin (BK) B2 receptor using various kinin…”
    Get full text
    Journal Article
  16. 16

    Induction of kinin B 1 receptor‐dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery by Pruneau, D., Luccarini, J.M., Robert, C., Bélichard, P.

    Published in British journal of pharmacology (01-04-1994)
    “…Balloon catheter injury to the rabbit carotid artery damaged the endothelium and induced neointima formation over 7 days. The area of intima, expressed as a…”
    Get full text
    Journal Article
  17. 17

    LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats by Schulz, J, Plesnila, N, Eriskat, J, Stoffel, M, Pruneau, D, Baethmann, A

    Published in Acta neurochirurgica. Supplement (01-01-2000)
    “…Head injury world wide is still the most frequent cause of morbidity and mortality among the population under 45 years. Approximately 50% of patients dying…”
    Get more information
    Journal Article
  18. 18

    Comparison of contractile responses to 5‐hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2‐receptor agonist, U46619 by Cocks, T.M., Kemp, B.K., Pruneau, D., Angus, J.A.

    Published in British journal of pharmacology (01-09-1993)
    “…1 The interaction between the thromboxane A2 receptor agonist, U46619 and two 5‐hydroxytryptamine (5‐HT) receptor agonists, the non‐selective, naturally…”
    Get full text
    Journal Article
  19. 19

    ω‐Conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries by Pruneau, D., Angus, J.A.

    Published in British journal of pharmacology (01-05-1990)
    “…1 We have investigated the effects of the N‐type calcium channel blocker, ω‐conotoxin GVIA, on contractile responses to nerve stimulation, noradrenaline and…”
    Get full text
    Journal Article
  20. 20

    Interleukin 8 (IL-8) induces the expression of kinin B1 receptor in human lung fibroblasts by Bastian, S, Paquet, J L, Robert, C, Cremers, B, Loillier, B, Larrivée, J F, Bachvarov, D R, Marceau, F, Pruneau, D

    “…Kinin B1 receptors are induced by various inflammatory mediators. The aim of the present study was to investigate the effect of the CXC chemokine IL-8 on kinin…”
    Get full text
    Journal Article